Clinical trial

MMP-9/NGAL Modulation by Piper Crocatum in Early Diabetic Nephropathy

NCT06676124

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-06-15

PhaseNA

Study timeline

Study start (actual)2024-06-15Date precision: day

Registry last updated2024-11-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Early Renal Dysfunction in Diabetesunresolved

Diabetic Nephropathyunresolved

Inflammation and Oxidative Stress in Diabetic Patientsunresolved

Interventions

Piper crocatum Extract CookieDIETARY_SUPPLEMENT

Placebo ComparatorDIETARY_SUPPLEMENT

Sponsors & collaborators

Hasanuddin Universitylead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06676124 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.